Preterm Birth and PROM Testing Market Analysis, Size, Growth, Share,Demand Outlook & Forecast to 2025
The global preterm birth and prom testing market size is expected to reach USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 1.8% during the forecast period. Rising incidence of preterm births, increasing geographical reach by market players, high demand for effective diagnosis of preterm births, and advanced drug delivery devices are expected to drive the market. Every year, approximately 15 million babies around the world are born before the 37th week of pregnancy and this number is expected to increase further. Around 1 million children die each year due to complications caused by preterm births. Premature Rupture of Membranes (PROM) causes about 4.5 million preterm births each year, worldwide. Globally, preterm birth is among the most frequent causes of death among neonates within the first month of life. Increasing average age of pregnant women (>35 years of age) has led to an increase in the risk of heath conditions such as high blood pressure and reduced blood flow to the placenta. These issues risk the health of both mother and unborn child and often result in preterm births or neonatal deaths. Even though traditional methods such as Nitrazine and Ferning test make it possible to obtain a negative predictive value (NPV), they have extremely poor positive predictive values for spontaneous deliver. The approval of PartaSure (Parsagen Diagnostics, Inc. and Qiagen) in April 2018 and other improved diagnostic test kits has introduced a highly efficacious yet cost-effective options for PROM testing in symptomatic patients. Preterm Birth and PROM Testing Market Report Highlights